Vanqua Bio
Home Page
United States · Founded 2019 · $136.0M raised
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- vanquabio.com
- Total Funding
- $136.0M
- Last Round
- $45.0M Series BSep 2021
- Rounds
- 3
About
Biopharmaceutical company focused on discovering next-generation medicines for neurodegenerative diseases.
Summary
Vanqua Bio is a Biotech company based in United States, founded in 2019. It has raised $136.0M in total across 3 rounds, most recently a $45.0M Series B round in Sep 2021. Investors include OrbiMed, Omega Funds and Surveyor Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...